论文部分内容阅读
应用硫酸镁抑制频繁或规律宫缩后，改服用硫酸舒喘灵抑制宫缩的方法对７６例早产病人进行治疗观察，并与未用药物治疗的４６例早产者对照。结果显示：硫酸镁与舒喘灵联合应用保胎组抑制宫缩成功６４例，总成功率为８４．２１％。先兆早产延长妊娠３５．３０±２４．７９ｄ，早产临产延长１４．０６±２０．１３ｄ，统计学处理差异有显著性（Ｐ＜０．０１）。用药组新生儿出生后窒息率及围产期死亡率均低于对照组（Ｐ＜０．０５），但产妇产后出血及出血量比较差异无显著性。故认为用硫酸镁抑制早产的急性宫缩，舒喘灵巩固硫酸镁的疗效，抑制宫缩的再度出现这一治疗是安全、可靠、有效的方法，值得应用。
Application of magnesium sulfate inhibition of frequent or regular contractions, change to take the method of inhibition of ursolic acid sulfate on contractions 76 cases of preterm patients were observed and compared with 46 cases of premature children without drug treatment control. The results showed that: magnesium sulfate and salbutamol combination of tocolytic group to inhibit the success of contractions in 64 cases, the total success rate was 84.21%. Prostate prolonged pregnancy prolonged 35.30 ± 24.79d, prolonged preterm labor 14.06 ± 20.13d, statistically significant difference (P <0.01). The asphyxia rate and perinatal mortality rate of newborn babies in treatment group were lower than those in control group (P <0.05), but there was no significant difference in postpartum hemorrhage and hemorrhage between two groups. Therefore, the use of magnesium sulfate inhibition of preterm labor of acute uterine contractions, salbutamol cure the efficacy of magnesium sulfate, inhibition of uterine re-emergence of this treatment is safe, reliable and effective method, it is worth applying.